tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Driscoll, 199 are a BUY (88.44%), 25 are a HOLD (11.11%), 1 are a SELL (0.44%).
Analyst Robert Driscoll, currently employed at WEDBUSH, carries an average stock price target met ratio of 40.2% that have a potential upside of 62.67% achieved within 159 days.
Robert Driscoll’s has documented 441 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KURA, Kura Oncology at 06-Feb-2025.
Analyst best performing recommendations are on ABUS (ARBUTUS BIOPHARMA CORP).
The best stock recommendation documented was for ABUS (ARBUTUS BIOPHARMA CORP) at 10/9/2018. The price target of $5 was fulfilled within 1 day with a profit of $1 (16.67%) receiving and performance score of 166.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$1.71 (51.98%)
$5
25 days ago
(21-Jan-2025)
0/17 (0%)
$1.79 (55.76%)
Buy
$5
$1.71 (51.98%)
$4
2 months 26 days ago
(20-Nov-2024)
4/11 (36.36%)
$1.56 (45.35%)
136
Buy
$5
$1.71 (51.98%)
$4
6 months 13 days ago
(02-Aug-2024)
2/6 (33.33%)
$1.26 (33.69%)
256
Buy
$5
$2.08 (71.23%)
3 years 14 days ago
(02-Feb-2022)
0/1 (0%)
$2.11 (73.01%)
Buy
$7
3 years 7 months 18 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Robert Driscoll is most bullish on?
Which stock is Robert Driscoll is most reserved on?
What Year was the first public recommendation made by Robert Driscoll?
